Welcome to JCDC
Precision is the accuracy in the working.
the truthfulness in the dealings.
precision is what drives us all.
Welcome to JCDC
Ethics are the morals that guide.
the principles that lay down the
foundation. the values that bind.
Ethics is what carries us all.
Our services

Jehangir Clinical Development Centre (JCDC) is a pioneering institution of world-class investigator sites in India. 

Watch video

JCDC provides clinical research services for pharmaceutical and biotechnology product development from Phase I to Phase IV

Health Care
Online Virtual Visits
Team Work
Life-changing care
Flexible Schedules
The Culture

At JCDC, We maintain the highest level of ethics, integrity and transparency in our interactions with patients and in our relationships with our customers. 


Caring for those who care for Patients

0 +

Clinical Studies Completed

0 +

Patients Benefited

0 +

Study Visits Completed

Features & Benefits

JCDC has a dedicated building with 10,000 sq ft space across 4 offices within the hospital premises exclusively for conducting clinical trials. JCDC offers excellent outpatient facilities with extended hours to accommodate the needs of our subjects.

Temperature and humidity controlled drug storage with automated continuous temp monitoring. Refrigeration & Freezer storage (2-4 Deg, – 80 Deg, Cryopreservation)

DEXA Scanner, PQCT, Jumping Mech, Jamar. Hand Dynamometer, Skinfold, Thickness Calipers, 12 Lead ECG, Cooling Centrifuge

Accredited and highly experienced IRB, IRB registered with CDSCO, Meetings conducted every month, Institutional as well as Central IRB capabilities

NABH Accredited Ethics Committee registered with DCGI, GCP trained Investigator network of 50+ investigators, Successfully completed 50+ Sponsor audits, Successfully completed an USFDA Inspection with no action indicated

Latest News

Four sites in Pune likely to be part of human clinical trials of Oxford Covid-19 vaccine

Phase 2 trials of Oxford vaccine to begin today (indiatimes.com)

Frontrunner Oxford vaccine for Covid-19 cleared for advanced trial in India